MorphoSys AG at JPMorgan Healthcare Conference Transcript
Good afternoon and good evening. I'm James Gordon, JPMorgan European Pharma and Biotech analyst. And today, at JPMorgan conference, I've got the pleasure of introducing the MorphoSys presentation and Q&A.
So we can have MorphoSys' CEO, Jean-Paul Kress, joining us at this 20-minute presentation, 20 minutes of Q&A afterwards and will be joined by the Board of management team.
And with that, I said, thanks a lot for joining us today, Jean-Paul, and looking forward to the presentation.
Thank you, James. It's a pleasure to be here today to share our exciting progress and plans for the future.
On Slide 2, you can find our forward-looking statements before we begin on Slide 3.
At MorphoSys, we are working every day to bring new medicines and hope to people living with cancer. Our goal is to have a profound impact on the lives of cancer patients. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
